ATE512967T1 - Als kinaseinhibitoren geeignete pyrrolotriazinverbindungen - Google Patents

Als kinaseinhibitoren geeignete pyrrolotriazinverbindungen

Info

Publication number
ATE512967T1
ATE512967T1 AT06785986T AT06785986T ATE512967T1 AT E512967 T1 ATE512967 T1 AT E512967T1 AT 06785986 T AT06785986 T AT 06785986T AT 06785986 T AT06785986 T AT 06785986T AT E512967 T1 ATE512967 T1 AT E512967T1
Authority
AT
Austria
Prior art keywords
kinase inhibitors
compounds suitable
pyrrolotriazine compounds
pyrrolotriazine
pyrrolotriazine derivative
Prior art date
Application number
AT06785986T
Other languages
English (en)
Inventor
Ping Chen
Derek J Norris
Ashvinikumar V Gavai
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE512967T1 publication Critical patent/ATE512967T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06785986T 2005-07-01 2006-06-29 Als kinaseinhibitoren geeignete pyrrolotriazinverbindungen ATE512967T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69639005P 2005-07-01 2005-07-01
US69639405P 2005-07-01 2005-07-01
US70308605P 2005-07-28 2005-07-28
PCT/US2006/025632 WO2007005631A1 (en) 2005-07-01 2006-06-29 Pyrrolotriazine compounds useful as kinase inhibitors

Publications (1)

Publication Number Publication Date
ATE512967T1 true ATE512967T1 (de) 2011-07-15

Family

ID=37146496

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06785986T ATE512967T1 (de) 2005-07-01 2006-06-29 Als kinaseinhibitoren geeignete pyrrolotriazinverbindungen

Country Status (4)

Country Link
US (1) US7405213B2 (de)
EP (1) EP1899346B1 (de)
AT (1) ATE512967T1 (de)
WO (1) WO2007005631A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY28931A1 (es) 2004-06-03 2005-12-30 Bayer Pharmaceuticals Corp Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
KR101487027B1 (ko) * 2005-09-30 2015-01-28 미카나 테라퓨틱스, 인크. 치환된 피라졸 화합물
PE20070855A1 (es) * 2005-12-02 2007-10-14 Bayer Pharmaceuticals Corp Derivados de 4-amino-pirrolotriazina sustituida como inhibidores de quinasas
WO2007064931A2 (en) * 2005-12-02 2007-06-07 Bayer Healthcare Llc Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
EP2166849A4 (de) * 2007-06-11 2010-09-15 Miikana Therapeutics Inc Substituierte pyrazol-verbindungen
CA2700489A1 (en) * 2007-09-25 2009-04-02 Bayer Healthcare Llc Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
ES2539620T3 (es) 2008-12-19 2015-07-02 Cephalon, Inc. Pirrolotriazina como inhibidor de ALK y de JAK2
CN103304489B (zh) * 2012-03-16 2015-03-11 中国农业科学院兰州畜牧与兽药研究所 嘧啶苯甲酰胺类化合物及其制备和应用
FI4063364T3 (fi) * 2019-11-18 2024-11-19 Jumbo Drug Bank Co Ltd Mnk-inhibiittoreina toimivat pyrrolotriatsiiniyhdisteet
WO2025092340A1 (zh) * 2023-11-03 2025-05-08 成都嘉葆药银医药科技有限公司 吡咯并三嗪类化合物在制备预防和/或治疗纤维化或其相关疾病的药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4649046B2 (ja) 1999-05-21 2011-03-09 ブリストル−マイヤーズ スクイブ カンパニー キナーゼのピロロトリアジン阻害剤
US6982265B1 (en) * 1999-05-21 2006-01-03 Bristol Myers Squibb Company Pyrrolotriazine inhibitors of kinases
GEP20063915B (en) 2000-11-17 2006-09-11 Bristol Myers Squibb Co PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS AND USE THEREOF FOR TREATING p38 KINASE-ASSOCIATED CONDITIONS
US6670357B2 (en) * 2000-11-17 2003-12-30 Bristol-Myers Squibb Company Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
PT1497019E (pt) * 2002-04-23 2015-09-10 Bristol Myers Squibb Co Compostos de pirrolotriazina anilina úteis como inibidores de quinase
TWI329112B (en) 2002-07-19 2010-08-21 Bristol Myers Squibb Co Novel inhibitors of kinases
AU2003265349A1 (en) 2002-08-02 2004-02-23 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
TW200420565A (en) * 2002-12-13 2004-10-16 Bristol Myers Squibb Co C-6 modified indazolylpyrrolotriazines
US7102002B2 (en) * 2004-06-16 2006-09-05 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
US7173031B2 (en) * 2004-06-28 2007-02-06 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors

Also Published As

Publication number Publication date
US20070004733A1 (en) 2007-01-04
EP1899346B1 (de) 2011-06-15
US7405213B2 (en) 2008-07-29
WO2007005631A1 (en) 2007-01-11
EP1899346A1 (de) 2008-03-19

Similar Documents

Publication Publication Date Title
NL301145I2 (nl) Tirbanibulin
EA200900798A1 (ru) Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы
CU20070160A7 (es) Pirrolopirazoles, inhibidores potentes de quinasa
UA101478C2 (ru) Соединения, полезные как ингибиторы raf-киназы
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
TW200801008A (en) Protein kinase inhibitors
EA201070247A1 (ru) Ингибиторы протеасом
NO20081636L (no) FAP - inhibitorer
ECSP078013A (es) Inhibidores heterocíclicos de mek y métodos de uso de ellos
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
EA200870415A1 (ru) Хиназолины для ингибирования pdk 1
ATE530540T1 (de) Pyrimidonverbindungen als gsk-3-inhibitoren
BRPI0821151A2 (pt) Derivados de pirazol e uso dos mesmos como inibidores de quinases dependentes de ciclina
ATE492545T1 (de) Verbindungen und zusammensetzungen als proteinkinase-hemmer
NO20076447L (no) Bicykliske derivater som modulatorer av ionekanaler
EA200900819A1 (ru) Хиназолины для ингибирования pdk1
GT200600035A (es) Aminopiridinas como inhibidores de beta-secretasa
ATE482213T1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
NO20092658L (no) New compounds
NO20090157L (no) Tienpyrimidiner anvendelige som modulatorer av ionekanaler
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
NO20071127L (no) Triazoloftalaziner
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
DE602006013191D1 (de) Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties